← 홈

프로그램 비교

검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-8 · 마지막 7월 21일

현재 선택: 1

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

API CSV22행 · 1개 프로그램

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목
CGTPhase 1
High (injection of scAAV2-P1ND4v2 2.4 X10e10vg, injection of scAAV2-P1ND4v2 2.4 X10e10vg (High))
Byron Lam·Leber's Hereditary Optic Neuropath…
ORR 0.03%
Overview
Program
injection of scAAV2-P1ND4v2 2.4 X10e10vg (High)
Overview
Company
Byron Lam
Overview
Modality
CGT
Overview
Target
Leber's Hereditary Optic Neuropathy
Overview
Indication
Leber's Hereditary Optic Neuropathy
Overview
Phase
PHASE_1
Overview
Status
ACTIVE
MoA
Mechanism
checkpoint inhibitor‑induced myocarditis from direct cardiac invasion in patients with lung cancer, particul
MoA
Biomarker
biomarkers normalized
PK/PD
Species
Mouse
PK/PD
Animal (cat.)
Mouse, In vitro
PK/PD
Experiment
PD
Toxicology
Species
Mouse
Toxicology
Animal (cat.)
Mouse, In vitro
Toxicology
Major finding
Nitric Oxide-Mediated Modulation of Photorespiratory Enzymes and Photochemical Components in Leaves of Pea Plants (Pisum sativum).. The photorespiratory metabolism safeguards photosynthesis against abiotic and biotic stress. Nitric oxide (NO) and reactive oxygen species (ROS) levels rise in plants during abiotic stress. Low concentrations of NO or ROS are beneficial as signalling molecules, but th…
Toxicology
CRS
Reported
Clinical
Primary efficacy
ORR 0.03%
Clinical
ORR
1.03%
Clinical
Result source
ClinicalTrials.gov NCT02161380
Clinical
Data Tier / Score
A · 27
Clinical
Program phase
PHASE_1
Clinical
Clinical sync
2026년 7월 18일 (8일 전)